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Abstract
Clinical exome sequencing (CES) is an established method for genetic diagnosis that is
commonly used in clinical practices. Studies examining the CES experience for families have
primarily been non-Latino white participants who speak English. To begin to address how these
experiences may differ in other populations, we conducted in-depth semi-structured interviews.
Interviews were completed with 22 Latino parents (14 in English; 8 in Spanish) of children who
had pediatric CES at Columbia University Medical Center and received results within three to 20
months of the interview. We also measured acculturation with a standardized scale. Similar to
prior studies, parents reported varied emotional reactions to their child’s results. Parents largely
understood their child’s CES results though were not always able to correctly recall recurrence
risk. The majority of participants reported feelings of anxiety while waiting for CES results.
Some parents, particularly those not fluent in English with lower acculturation scores, reported
language barriers to their understanding of the testing and their child’s care. Faith appeared to be
a positive coping mechanism that was more frequently reported by participants with lower
acculturation scores. Our findings are consistent with many of the previous studies of parental
experience of CES but highlight some key findings that warrant further study and potentially
inform practice. Larger studies should explore potential associations between acculturation and
parental understanding or emotional response to results. The minimal language barriers reported
by Spanish-speaking patients reiterates the importance of a Spanish-speaking provider, when
possible, and bilingual resources.
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Introduction
Clinical exome sequencing (CES) is an established method for genetic diagnosis.
Implementation of CES as a first or second tier test provides an earlier diagnosis, eliminates the
cost of traditional testing, and increases the diagnostic yield compared to the standard of care
(Valencia et al. 2015; Kuperberg et al., 2016; Nolan & Carlson, 2016; Vissers et al., 2017).
Research to date has demonstrated mixed motivations for obtaining CES, including a
sense of duty, lack of other options, hope for a diagnosis and the potential for it to guide care and
treatment (Rosell et al., 2016; Wynn et al., 2018). Many parents report feeling that any
information at all could improve their quality of life and sense of empowerment (Clift et al.,
2015; Wynn et al., 2018), though previous failed attempts at diagnosis can reduce expectations
of a diagnosis for parents of children getting CES (Rosell et al., 2016). While a hope for a
diagnosis was often reported as motivation for testing, parents also feared receiving a diagnosis
that indicated a shortened lifespan, and implications for their insurance (Rosell et al., 2016, Clift
et al., 2015).
Similar to motivations for testing, reactions to test results are often mixed. Parents felt
frustrated and sometimes depressed by their CES results (Rosell et al., 2016, Wynn et al., 2018).
Parents who received a definitive diagnosis for their child experienced relief and appreciation,
while others experienced a loss of hope by the lack of therapeutic options or isolation by the
rarity of the diagnosis. Parents who received a possible diagnosis mostly experienced
hopefulness as they continued to search for a diagnosis, or acceptance at not receiving a
definitive diagnosis. However, those who received no diagnosis either experienced relief that
nothing was found, or concern and disappointment as they still sought a reason for their child’s
symptoms (Krabbenborg et al 2016; Rosell et al., 2016).

Parental reaction may also have effects on comprehension of genetic information. In
instances where the emotional impact is high, parents are less likely to process information
which can result in a feeling of being overwhelmed. Parental experiences are perceived as
positive when a dialogue is present between the geneticist and the parent without excessive
jargon, emotional support is provided, and there is inclusion of medical management suggestions
(Ashtiani, Makela, Carrion, & Austin, 2014; Browner, Preloran, Casado, Bass, & Walker, 2003;
Walser et al., 2017).
With adequate pre-test counseling, parents have been able to accurately explain their
results and explain the limitations of the CES (Rosell et al., 2016). Parents often request variants
of uncertain significance (VUS) returned, although there may be confusion about their
significance (Rosell et al., 2016, Wynn et al., 2018). In terms of secondary findings, parents may
be willing to learn about them because they believe it may help them contribute to research and it
may inform decisions about medical management (Clift et al., 2015).
A study by Wynn et al. found that most parents were able to correctly interpret their
child’s CES results, and most discrepancies were due to the clinician’s reinterpretation of the
laboratory report or the return of negative or uncertain results. Timing of testing also impacted
parental perception, with a lower positive impact associated with increasing age of the child. The
overall experience was perceived as positive in parents who interpreted the CES results as
positive. However, one major limitation noted in this study was that most of the participants
identified as white, non-Latino (2018).
The ethical principle of justice in research dictates that all groups of people are invited to
participate in research. The US population of Latinos is about 17.8% and is projected to increase
to 28.6% by 2060 (United State Census Bureau, 2017). Despite this, most research on genetic

disease susceptibility has been done on non-Latino white individuals (Kinney, Gammon,
Coxworth, Simonsen, & Arce-Laretta, 2010; Wynn et al., 2018). Members of minority groups
are also less aware of genetic testing as compared to Caucasians (Hann et al., 2017).
The Latino population remains underrepresented in genetic research. Language barriers,
discrimination, low numeracy and literacy, higher rates of being uninsured, lower household
incomes, and a higher rate of poverty are some of the barriers to implementing genetics into their
healthcare (Kamara, Weil, Youngblom, Guerra, & Joseph, 2018).
Ponce et al. (2006) found that English language skills correlated with better health
outcomes even when race, age, and income are controlled for. Less proficiency in English
corresponds with lower health literacy and fewer regular visits to the doctors (Bruce et al., 2014;
Kamara et al., 2018). In addition, physicians view non-English communication as a barrier to
informed consent or interest in medical care (Bruce et al., 2014). Patients required to assess
themselves in a language they are not fluent in report themselves as more unhappy, less
confident, and even less intelligent in the subject matter (Wallin & Ahlström, 2006). Research
into the attitudes and beliefs of Spanish-speaking people is important to developing public
awareness among these people (Kinney et al., 2010).
Healthcare disparities can alter disease course in minorities. Breast cancer is detected at a
later stage in Latina women, even while controlling for education, socioeconomic status, and
detection method (Lantz et al., 2006). This discrepancy is reduced when controlling for detection
method, but only in Caucasian and African American women and not Latinas, suggesting that
cultural differences unique to Latinas may outweigh racial differences (Lantz et al., 2006).
When communicating genetic testing results, Latino patients request that the information
be disclosed slowly and without technical jargon (Browner et al., 2003; Kamara et al., 2018).

Better outcomes have been demonstrated for patients who speak English when receiving a
genetic diagnosis (Krabbenborg et al., 2016). In addition, people coming from a lower
socioeconomic status (SES) have been shown to be accustomed to addressing immediate health
concerns and less concerned with planning for future events (Kamara et al., 2018). Latinos are
sometimes used to being given a much more paternalistic treatment by their doctors and may see
non-directiveness as indication that something is not important (Browner et al., 2003; Kamara et
al., 2018; Vadaparampil et al., 2010).
Not only can there be communication barriers between providers and the Latino
population, but access to genetic testing may be limited as well. Fewer genetic tests are ordered
and fewer referrals to genetic counseling are made by physicians who serve mostly minorities
(Shields, Burke, & Levy, 2008). This discrepancy may be related to competing health priorities
among minorities (who tend to present to care sicker and receive more emergency care), the
lower level of board certification of minority-serving physicians, or simply minority patients
being offered less genetic testing (Shields et al., 2008). Other barriers to genetic testing among
Latinos are similar to reported barriers to general healthcare including logistical concerns insurance status and competing life concerns, such as childcare and other life responsibilities
(Sussner, Jandorf, Thompson, & Valdimarsdottir, 2013). The issue of “competing life concern”
was reported by Sussner as the biggest barrier to Latinas pursuing testing, and made them less
likely to undergo BRCA1/2 testing (2013).
In addition to considering how to tailor information to the Latino population, their
perception of genetic testing could influence how information is received. Not much is known
about the psychosocial and emotional reactions to genetic testing that are unique to Latinos
(Hickey et al., 2014; Kinney et al., 2010). Male Latinos tend to experience anxiety around

personal peril and employment-related barriers, while females tend to be concerned with heredity
implications of genetic diseases, such as how it would affect their children and pain associated
with genetic testing (Hamilton et al., 2016, Hickey et al., 2014). Latinos perceive the risk of
emotional harm from genetic testing to be higher than Caucasians do, though both ethnicities
have relatively low levels of perceived risk of harm (Palmer et al., 2008). Fatalistic attitudes can
prevent Latinos from recommending testing to other people (Vadaparampil et al., 2010).
Latinos have been shown to want genetic testing for the purpose of helping affected
individuals, their families, and other families, as well as to learn recurrence risk or to explain
family history, whereas non-Latino Caucasians more frequently reported discovering the
etiology of a disease as reasons to pursue testing (Palmer et al., 2008). However, a more recent
study found that there was no significant differences between Latina and non-Latina women in
perceived benefits or desired counseling topics in a hereditary cancer setting (Gammon et al.,
2011). Studies show Latinos understand the basics of genetic testing and believe that it can
provide valuable health information and may lead preventative measures; however, language
barriers are listed as a hindrance to doctor-patient communication and the purpose of genetic
testing, how it is performed, and the information it provides are less well understood (Hamilton
et al. 2016).
Latina women have misconceptions about BRCA1/2 genetic testing, unawareness of
familial breast and ovarian cancer, and ignorance about the availability of genetic risk
assessment. Benefits of genetic testing reported by these women included information for their
children and future generations (Kinney et al., 2010).
In addition, attitudes toward genetic testing in Latinos are often influenced by levels of
acculturation, or the degree to which an individual from a minority culture has adopted the

mainstream culture. Latino women with lower acculturation tend to be diagnosed with breast
cancer at a later stage than their more acculturate peers (Lanz et al., 2006). Knowledge of genetic
testing is lower among Latinos than non-Latino whites, but this knowledge gap becomes smaller
with increased acculturation (Sussner, Thompson, Valdimarsdottir, Redd, & Jandorf, 2009). As
acculturation increases, Latinos report fewer barriers, more perceived benefits, and more
favorable attitude towards genetic testing (Sussner et al., 2009).
One social barrier that cultural sensitivity can ease is the language barrier. Some medical
terms in English may not have an equivalent in the patient’s language, making it difficult for
both translators and interpreters. In addition, when translating from one language to another, the
concept or meaning of the sentence may be altered unintentionally which can skew results in a
qualitative interview. Interpretation also depends on the skill level of an interpreter and their
ability to interpret effectively.
Despite the recognized effects of a language barrier, this is infrequently addressed in
qualitative studies. Qualitative interviews have been used in many studies to determine a
patient’s perception, but few studies have explored the effect of the language barrier. A review of
40 scientific cross-language qualitative studies found that researchers often do not acknowledge
language barriers as a possible limitation of their study and do not explore the possibility of it
affecting the analysis and interpretation of results. In addition, only seven studies pilot tested
their interview guides in the native language of the participants, and half of the studies did not
mention the credentials of the interpreter or at which point in the interview the interpreter was
used (Squires, 2009).
This study aims to identify both common and unique themes pertaining to the Latino
population and their experience of CES results. These themes include, but are not limited to, the

parental experience of education and consenting, initial reactions to the CES results, their
decision to have testing, the experience of waiting for and receiving results, and the resources
received and needed throughout the process. Barriers to their genetic healthcare will also be
explored.
The projected increase in the Latino population within the United States highlights the
need for minority populations to be significantly represented within healthcare research. This is
the first study that aims to understand the experience of Latino parents who have had CES on
their children. The findings from this study can be used to identify barriers to genetic testing in
Latinos, and more specifically, the challenges associated with genetic testing when involving a
child with a genetic condition. The results of this study have the potential to improve their
healthcare in a positive manner by including genetics.

Methods & Materials
This study was carried out in the Division of Clinical Genetics at Columbia University
Medical Center (CUMC) in New York City. Interview guides and participant contact materials
were developed by the authors and translated by bilingual research assistants, and subsequently
approved by the Columbia University Institutional Review Board. Interview guides assessed
themes which were identified from the literature as having special relevance to the Latino
experience with healthcare (access, language barriers, competing life concerns, cost, etc.) as well
as recognized themes related to receiving genetic test results (impact of testing, sharing results,
emotional reaction to and understanding of results).

Participants
The participants for this study were parents of Latino/a pediatric patients who had
undergone CES at CUMC. Parents were seen in clinic and results session by various members of
a team of seven genetic counselors, one of whom was Spanish-speaking, and one of five
geneticists, two of whom were Spanish-speaking. A sample of participants were recruited from a
database of patients who undergone CES at CUMC in the years 2017 and 2018. Latino
participants (n=102) were selected for by filtering ethnicity of proband, parents, or grandparents
as “Hispanic” or “not given,” “Country of Origin” for proband or parents as any Latin American
country, and “Primary Language” as “English,” “Spanish,” or not listed. Subjects were further
stratified by those receiving CES results between six to 18 months ago.
Procedure
The parents of each participant were contacted by invitation letter in both English and
Spanish from their treating provider. Invitation letters were followed by up to three invitation
phone calls made by English-speaking or bilingual RAs. Verbal consent was obtained, and
interviews were scheduled. Consent forms were sent to enrolled subjects either electronically
through email link to REDCap (Research Electronic Data Capture) or paper forms through the
mail. Subjects’ contact history, consents, and interview schedules were tracked in REDCap.
In-depth, semi-structured interviews were conducted in either in English or Spanish based
on participant preference. Interviews lasted between 30-60 minutes and were conducted by
phone by one of two genetic counselors (JW, CK) and attended by genetic counseling interns
(RS, DL) or a bilingual research assistant (KR). Data collection continued until saturation and all
interviews were audiotaped. English interviews were transcribed verbatim by a private

transcription service. Spanish interviews were first transcribed and then translated by bilingual
Latina research assistants KR or AE. To improve reliability, translation was completed first by
one RA and then selected quotes were reverse translated (translated back into Spanish) by the
second RA.
After each interview, subjects were sent an 8-question survey designed to assess
acculturation. six questions were from Marin’s Short Acculturation Scale for Hispanics (SASH),
addressing language use and preferences, and was used as a measure of acculturation. Two
additional questions were the authors’ own and regarded language use with healthcare providers
and at work. Responses were on a 5-point Likert scale of “only Spanish” to “only English,” with
higher scores indicating greater levels of acculturation. Subjects were sent a $25 Amazon gift
card to compensate them for their time.
Data Analysis
Transcripts were uploaded and coded in NVivo software (QSR International Inc.,
Burlington, MA, USA) in a three-stage process by three researchers. Participant narratives were
reviewed using inductive thematic text analysis, a process of transcript review, interpretation,
and consensus discussions. Transcripts were coded by researchers JW, RS, and DL on a rotating
schedule. Primary coding was performed by the assigned researcher for the designated transcript.
After completion, another researcher was assigned to secondary coding. After secondary coding,
the final researcher performed tertiary coding. Methodological and analytical documentation
included the identification of key phrases, similar experiences, common themes, and
documentation of the subject reaction to the CES experience. All three researchers completed an
analysis of each.

Results
Demographics
In total, 22 parents were interviewed. Of those parents, 4.5% (N=1) were male and 95.5%
(N=21), were female, ranging in age from 24 to 53 years old at the time of the interview with an
average age of 36. Most parents completed high school (86.4%, N=19) and some had a college
degree (22.7%, N=5). Sixty-eight percent (n=15) of parents were employed full-time or parttime, while 32% (n=7) were unemployed. Sixty-four percent (n=14) of parents were married and
36% (n=8) were single. Fourteen parents elected to be interviewed in English and eight in
Spanish. Besides one father, all of the participants were the mother of the child tested. All
parents spoke some Spanish and the majority (86.4%) (n=19) identified Spanish at their primary
language or both Spanish and English as their primary languages. Four (18.2%) parents reported
they spoke no English. A minority (13.6%, n=3) of parents reported English as their single first
language.
Parents had acculturation scores between 4.25 and 1.00. Ten (45.5%) of parents had a
low acculturation score, classified by a score of 2.99 and below. Twelve (54.5%) parents had a
high acculturation, classified by a score of 3.0 or above. Low-acculturated parents had an
average acculturation score of 1.72, while high-acculturated parents had an average score of
3.41. Of the low-acculturated parents, five held their genetics appointment in Spanish with a
Spanish-speaking provider, two spoke Spanish and used a translator, and three spoke in English.
Nine of the 10 low acculturated parents spoke Spanish in the interview for this study. Of the
high-acculturated parents, 10 spoke English during their genetics appointment and two spoke in
Spanish with the providers. All 12 high acculturated parents spoke English in our interviews
(Table 1).

The average age of the children was 8.4 years old, and 86.4% were insured through
Medicaid/Medicare. Ten children were female and 12 were male, ranging in age from 1.5 to 18
years old at the time of the interview. The most common clinical indications were developmental
delay (n=8), autism spectrum disorder (n=4), seizures (n=2), and hypotonia (n=2). Children were
seen in the genetics clinic by one of seven genetic counselors and one of five geneticists.
Thirteen were evaluated by a genetic counselor and/or geneticist who spoke Spanish, the other
nine either conducted their appointments in English or with the use of a translator. One child had
exome sequencing through her neurologist. The time from when parents received results to when
the interview was conducted ranged from 3-21 months with an average time of 13 months (Table
2).
All children received CES. Ten children (45.5%) had CES results which did not identify
any variants, 9 (40.9%) had pathogenic variants identified, and three (13.6%) had VUS
identified. Two children had negative CES results with a VOUS or pathogenic mutation on
previous panel or microarray. Of the pathogenic results, four (18.2%) were de novo, three
(13.6%) could not be determined because one or both parents had not been tested, one (4.5%)
was an X-linked disease maternally inherited, and one (5%) was an autosomal recessive
condition with bi-parental inheritance. Nine children (41%) had prior genetic testing before the
CES was ordered, eight (36%) had CES as a reflex test following an initial negative work up,
and seven children (32%) had CES concurrently with other testing. In addition to CES, 19
children (86%) had a karyotype and 21 children (95%) had a microarray, either before or at the
same time as CES. One child had CES ordered by a neurologist and it is unknown if a karyotype
or microarray were completed (Table 3).

Understanding of CES
In general, when asked to recall CES, parents provided a limited description and often
stated they were not familiar with the terms of exome sequencing. Most parents did not
distinguish CES from other genetic tests their child had concurrently or in an earlier work up,
though some recalled a discussion of the comprehensive nature of the testing or the occurrence
of parental sample collection. Though often unable to provide a detailed description of CES,
most parents felt comfortable with the information provided to them.
Motivations for CES
Families expressed an obligation to pursue testing, often expressing that they “had to find
out” what caused their child’s condition, regardless of treatment options (n=18). However, many
parents communicated that they had hoped that CES would provide a diagnosis for which there
was a treatment or cure for their child’s condition (n=6). While many parents expressed hope that
a genetic cause could be determined, several also hoped that a cause would not be found. Some
had ambivalent feelings about what they were hoping for.
A few also indicated the potential to provide information about the risk for other children
or to guide reproductive risk for themselves or their children as a motivation to have testing
(n=3). Several participants (n=3) were interested in the potential to learn about secondary results.
Many parents (n=14) also explained the testing with regards to how it would inform them of
inheritance, such as which side of the family the condition came from. Eleven parents described
the purpose of testing as partially to learn which parent had passed on the genes causing the
condition. Sometimes the question of inheritance was tied to feelings of guilt or fault.

Waiting for Results
Waiting for the results was frequently considered to be the most difficult part of the entire
CES process. When commenting about the amount of time expected for the results to arrive,
most patients remembered being told to wait three to four months. The only mother who
repeatedly contacted the hospital asking for her results did so at one and a half months, far earlier
than most others expected their results, and may have not understood the expected turnaround
time.
Experience with genetics and how results were received
Parents generally felt their experience in genetics was positive. With few exceptions, they
felt comfortable with their providers and felt their questions were answered. Five parents
reported feeling nervous or overwhelmed at various points in the testing process.
Some (n=11) recalled receiving the results first by phone, some recalled receiving them
through an in-person visit, and a few thought they learned the results in a letter. One could not
recall how they first learned the results. Three parents stated they thought receiving results by
phone was the best way, and three thought the results would have been better delivered in
person. Most were satisfied with how they received the results or agreed that there was no
perfect way. Two parents did not recall ever receiving the full results.
Understanding of and Reaction to Results
Parents had various reactions to the results, reacting both negatively (sadness, surprise,
mistrust, disappointment) or positively (hopeful, satisfied, or relieved). There was no noticeable
difference between parental emotional reaction and their acculturation levels. While some
parents expressed an initial disbelief in results, most expressed a trust in the results and the

prognosis. Some parents expressed the permanence of the results, though others, both with
negative and positive results, felt the results may change and may warrant testing in the future as
technology advances.

Positive Results (N=9)
Interpretation
Almost all parents of children who had a pathogenic variant understood this to be the
cause of their child’s condition (n=8). Two parents with de novo results were able to explain the
genetic cause did not come from them but were unsure about recurrence risk and had decided to
forgo having additional children due to the perceived risk of recurrence. Three of the parents
were able to name the condition of the diagnosis provided by the test. Most parents had already
been convinced there was a condition present in their child before the CES, and that the genetics
confirmed the condition’s presence.
Reaction
Emotional reactions to positive results were mixed. Parents of children who received
positive results often expressed strong negative emotions, such as being shocked, devastated,
unsatisfied, in disbelief, or sad (n=5, 62%). One parent reported that his wife doubted the
genetic etiology and believed vaccines were responsible for the child’s condition. A mother had
initially been told the results were negative and was in denial when she learned about the
diagnosis.
One parent who reported only a modest emotional reaction felt this was related to already
being aware that her child had a serious condition, and the results did not change this. Three
parents with positive results expressed hope that the results could lead to some treatment, while

two parents with de novo positive results expressed relief to learn they had not caused the
condition. One mother of a child with a de novo muscular dystrophy shared how the results
helped her to stop blaming herself.
VUS Results (N=3)
Interpretation
One parent had a child with a de novo VUS but interpreted the result as negative. She
reported wanting more information about why CES was performed. Another mother had a child
with a paternally inherited VUS and understood the uncertainty of the result, the inheritance, and
the recurrence risk. The mother of the child with the maternally inherited mitochondrial VUS
was confused about the result and thought further genetic studies were needed.
Reaction
Patients with VUS results reacted in a variety of ways, from confusion to unconcern. The
parent of the child with the de novo VUS reported being happy that there was nothing found but
was confused about why CES was performed and what clinicians expected the result to be.
Feelings of relief were expressed by the parent of the child with the paternally inherited VUS.
The mother of the child with the maternally inherited mitochondrial VUS was concerned about
inheritance and was fearful of a hereditary condition.
Negative Results (N=10)
Interpretation
Some parents (n=3) who received a negative CES result for their child seemed to
understand there was still the potential for a genetic diagnosis despite negative results. Two
participants expressed a wish for future treatments or testing options. Many parents (n=4) saw

CES as definitive and believed failure to find a variant meant that the child’s condition was not
genetic and understood negative results to have eliminated a potential genetic diagnosis. Two
parents had negative CES results but VUS on an epilepsy panel and did not distinguish between
the two tests. The parent whose child had a negative CES result but a de novo pathogenic
deletion on microarray also did not differentiate between the two tests.
Reaction
Parents who received negative results and felt the results ruled out a diagnosis expressed
happiness and relief (n=5). Two parents reported being unconcerned about the results due to the
distractions of caring for their families, one of whom never received the results. Other parents
with negative results were disappointed to not have an answer (n=3), though two of these parents
also felt glad the process had been done. One parent with a negative result was unsure if doing
the test was the right thing for her.
Timing of CES
Most parents (69%) would have liked to have had the testing done sooner, and no parents
wished for testing to be done later. Of the parents with pathogenic results who were asked if they
desired to have testing done sooner, all agreed. For parents who had negative or uncertain results
many were content with the timing of the test (67%), though some (n=2) would have liked to
have the testing done earlier.
Impact of CES
Regardless of the emotional impact of learning the results, almost all parents stated that
they did not regret doing the test or learning the results, and would do the test again. Relatively

few sought advice from others before undergoing CES, and none had doubts about the testing
process.
Most parents reported no significant impact on their lives regarding insurance, jobs, or
relationships, but genetic testing has made them more cautious for their other children, has
caused minor lifestyle changes, and has improved some of their medical interventions. Six
parents mentioned that there were no negative effects of the testing (2 negative, three VUS, one
positive). Eight parents mentioned that the tests did not affect their child’s care in any way, five
of them from the positive result group. Eight parents mentioned the results affected their
reproductive decisions or feelings about recurrence risk, most (n=5) had positive results. Five
parents were reassured there was little chance of recurrence, and one said she was considering
her previous decision to forgo reproduction. Another parent with a positive result said the result
allowed them to be prepared for a second affected child. A parent with a negative result was
uncertain of the implications of the test.
Three parents with positive results and one with a VUS mentioned access to a trial
treatment or some improvement in the care as a result of the genetic test. Three parents (one
VUS, two positive) mentioned considering a trial but not seeing improvements or not joining the
trial. One parent with a positive result explained they had undergone much personal growth
since the diagnosis. Another discussed being more cautious with her current child.
Sharing CES Results
All parents chose to share their child’s CES results with some family members, such as
their other children, their parents, grandparents, or their siblings. Some parents stated they had a
family meeting, while others reported they had family members who constantly checked in with
them about their child’s health. One mother of a child with a de novo muscular dystrophy

expressed difficulty explaining the condition because of limited information available and the
misconception that genetic conditions always run in families.
Others shared that members of their family were not as accepting of the results. The
father who was interviewed for the study stated that his wife did not accept the test results. She
believed vaccines were responsible for their child’s autism and planned to pursue direct-toconsumer testing (DCT) as a second opinion. Another mother of a child with seizures noted that
the father had unrealistic expectations that their child would recover or catch up.
Some parents (n=4) mentioned sharing the results with their friends, while others (n=4)
reported sharing their child’s diagnosis with the child’s school. Ten parents shared results with
healthcare providers. There were no overt patterns of sharing based on type of result. Parents
listed reasons not to share with others due to privacy concerns or their own judgement about who
they felt needed to know. Some stated that other people who knew about their child’s symptoms
before CES either did not believe the child’s symptoms were real, thought the symptoms were
due to the child’s upbringing, or believed in alternative remedies, which is why they chose not to
share the diagnosis.
Barriers to CES
The majority of parents did not report physical barriers to their genetics care such as time
off work, child care, and transportation. However, some parents reflected on the difficulty of
multiple appointments and taking time off work or finding child care. One mother who received
car service expressed exasperation with it and eventually purchased a car to attend appointments.
One parent who reported never learning the results of her child’s testing and not
following up to inquire about it expressed that it was not her priority given her child’s other

medical needs. Another parent experienced the death of her grandmother when the results
became available and she elected to delay the receipt of the results because of this.
Only two parents had an out of pocket cost of $7,000 and $200, respectively. The
majority of other parents (n=19) reported no cost of testing. Few recalled having a discussion
about potential cost at the time the testing was ordered. When asked about whether or not they
would have pursued the test had there been a cost, two indicated an upper limit of $1,000 and
$300 respectively, two mentioned they could not have afforded anything, and others (n=3) felt
they would have found a way regardless of the cost.
Language as a barrier
Only one participant used a phone translator during their genetics appointment. All other
parents who conducted the interview in Spanish had Spanish-speaking providers who either
spoke Spanish with them, chose to speak in English, or used a staff member to translate inperson. The Spanish-speaking parent who did not have a provider who spoke Spanish recalled
that a phone interpreter was used and reported problems with understanding. This parent reported
wanting more information and not understanding the reason for the test. Three of the parents
were able to communicate with Spanish-speaking doctors in the session. These parents reported
no problems with the communication. When asked directly if they were satisfied with the
information provided in session, only one parent who communicated with the doctor directly in
Spanish reported being unsatisfied.
All of our participants spoke at least some Spanish, but several said they preferred to
speak to providers in English. Three parents had concerns about not knowing as much medical
terminology in Spanish, and one expressed the preference for English based on the concern that
Spanish language encounters with providers could cause delay accessing records in case of an

emergency. Though each of these four parents said they were comfortable in Spanish, they
scored high on the acculturation scale (average of 3.5). One parent with an acculturation score of
4.25 reported being perfectly bilingual, and preferred Spanish for the benefit of the people who
attended the session with her. No parents with a low acculturation score preferred English with
their providers, and those who voiced a preference for Spanish had an average acculturation
score of 1.9 (n=5).
Additional Resources
Additional resources accessed by parents were the use of the internet, their job experience
in the healthcare field, or parents of other children with the same condition. Overall, Spanishspeaking, low acculturated parents had the most barriers regarding use of support groups. Only
one parent, noted to have high acculturation, was actively enrolled in a support group. Three
parents, all Spanish-speaking with low acculturation, expressed interest in attending a support
group, and two of these parents stated they were able to find resources in Spanish. One Spanishspeaking parent stated that she wanted to find resources but was discouraged because of the
language barrier, while another Spanish-speaking parent stated she would have liked therapy
with psychologists. However, one parent whose child has Neimann-Pick and stated that the
online support group provided to her by her child’s neurologist had a representative who could
communicate with her in Spanish.
Latino experience
Parents were asked how they felt their ethnicity or culture impacted their experience.
Many felt that it had little impact and often reflected on how they may differ from other Latinos.
Others expressed that the larger Latino community may have a different experience because of

cultural approaches to about health, such as belief in alternative treatments, lower education,
language barriers, and differences in how information and decisions about health are approached.
Some used the examples of specific family members and friends and hypothesized that they may
have relied more on their provider to make the decision to pursue testing, or have more difficulty
accepting a diagnosis or a prognosis. In terms of acculturation level, very little difference was
found in the experience of parents based on their acculturation levels.
Religion & Faith
Some parents occasionally used language relating to “God,” in vernacular such as “thank
God” or “oh my God” (n=3). Two mothers expressed faith that God could change something in
relation to their child’s genetic diagnosis while the other mother used her faith to come to terms
with her son’s diagnosis. All parents who made explicit mentions of faith were slightly above the
average age of parents in our study, had acculturation scores less than 1.5, and spoke Spanish
during the CES results session. However, one chose to speak English during their interview. All
three had children with pathogenic CES results, two of which were de novo and one where
inheritance was unknown.

Discussion
This study provides insight into the experiences and perceptions of Latina mothers and
one Latino father of children who have had CES. We examined how these experiences were
influenced by degree of acculturation. Overall parents reported the experience of having CES
performed on their children to be positive with few reporting negative experiences. Most
negative experiences were related to distress upon receiving a diagnosis, waiting for results, and
difficulties with language.

Most parents were unable to recall the term “exome sequencing” or describe the test in
any detail but were satisfied with their understanding and the information provided to them
regardless. The primary reasons for pursuing testing was a desire to learn everything possible
about their child’s condition, to obtain advice from providers regarding their child’s diagnosis,
and a hope for new therapies or treatments.
Reactions to results were influenced by type of result. Parents receiving positive results
often expressed feelings of shock or sadness and occasionally hope. Parents who received
negative results or VUSs often felt relief, confusion, and occasionally disappointment. Most
participants had good recall of their child’s CES results and an appropriate understanding of the
results.
We did not observe a difference in the understanding and interpretation of CES results
between high acculturated parents and low acculturated parents. This is somewhat inconsistent
with a previous quantitative study (N=120) of Latina women, which found increased
acculturation correlating with increased knowledge of genetic testing (Sussner et al., 2009).
However, we did not specifically ask about prior knowledge of genetic testing.
Few differences across acculturation levels were observed for barriers to testing, regrets
around testing experience, or satisfaction with the process of genetic testing. Spanish speaking
parents were more likely to express difficulty in communicating or understanding the providers,
and also in finding additional resources during and after the testing process. Similar to a study by
Rajpal, Munoz, Peshkin, & Graves, few participants felt that their cultural background personally
influenced their experience but agreed that for other Latino parents it might (2017).
Our findings of parents’ feelings of guilt about potentially passing down genetic
conditions contrasts with findings in a recent study of parents in South Africa. A study by

Gardiner et al (2018) showed that parents of children with hearing loss reported that discovering
a genetic etiology for the hearing loss would decrease their personal feelings of guilt. Only one
parent in our study also expressed the idea that discovering a genetic cause would remove their
feelings of guilt; many more reported apprehensions that the genetic testing would indicate that
one of the parents were at “fault” genetically for their child’s condition. Gardiner’s study had
findings which were concordant with ours, such as the perception that a genetic etiology was
associated with a positive family history.
Lack of diagnostic odyssey and its impact on parental reactions
The majority of the children in the study had CES as part of their initial genetic
evaluation or as reflex testing following negative first tier testing. This timing is in contrast with
other studies of parents of children with CES, where frequently, the child had CES after years of
evaluation (average of 78 months in the case of Valencia et al. 2015, and 91 months in Rosell et
al. 2016). This difference may account for some of the differences we observed in our study.
Many of the parents did not describe the CES testing experience as different than prior or other
genetic testing their child had or was having. In contrast, other studies have reported parents to
understand CES accurately as distinct from previous tests, with characteristics such as being
untargeted (Rosell et al. 2016).
While waiting for results has been reported as a source of frustration and disappointment
(Rosell et al. 2016), in our study, parents recalled the waiting period as a source of anxiety and
anticipation. As CES testing becomes part of second and even first tier testing, this will affect the
patient/parent experience. Their understanding of the testing may differ as they have had only
one or two appointments in genetics rather than many over a span of several years. The CES

process is likely one of the first times where parents have had to wait over a month for a test
result.
Faith as a coping mechanism
One theme that emerged was the use of faith and spirituality as a coping mechanism,
although we did not specifically ask about this during our interviews. Faith has been previously
explored as having a significant impact on the genetic testing decision-making process in
individuals who consider themselves religious. For these individuals, there is an added step in the
decision-making process. Some Latinos may believe genetic testing is punishable by God, while
others process their understanding of the diagnosis and treatment within the context of their faith
(Hamilton, et al. 2016; Scully, Banks, Song, & Haq, 2017). Clinicians are less likely to address
faith and are viewed as disengaged when patients mention their religion (Scully et al., 2017).
Faith has also been observed as a method of adaptation and resilience in Latinos with cancer.
This belief system aids in their acceptance of disease and they respond to illness to overcome
disease (Jurkowski et al. 2010; Hunter-Hernández et al. 2015).
Similar to other studies in a prenatal setting, we found that several parents, all with lower
acculturation levels, referenced back to their faith as a coping mechanism, expressing having
faith in God, waiting for a change from God, or believing their child’s condition was a result of
God (Thompson et al., 2015; Seth et al., 2011). We also noted that there may be generational
differences due to the Latinas referencing faith being above the average age of our participants.
Our cohort did not use their faith as a form of denial about their child’s condition, but rather as a
coping mechanism or form of acceptance. Recognizing that this need may be more frequent in
the Latino community could build additional rapport with parents and extract positive reactions
toward genetic testing in their children.

Language and Cost Barriers in Latinos
Our study found few language barriers encountered during the genetics appointment and
only occasional language barriers during the subsequent search for additional information or
resources. In fact, of the nine parents who we identified as having expressed misconceptions or
confusion about the implications of their results (incorrect recurrence understanding, dismissal of
positive results, believing that negative results signified no possible genetic etiology, confuse
CES and microarray results, or report not knowing the purpose of the CES), seven of those nine
were English speakers with high acculturation.
In past studies language barriers were a reported concern affecting the ability of Latino
patients to access genetic testing (Kamara et al., 2018; Kinney et al., 2010). Compared to these
two other studies, our cohort was less foreign born, more English speaking, younger, and more
educated. The lack of reported language difficulties in our study was most likely due to the
availability of Spanish-speaking receptionists, genetic counselors, and geneticists in the clinic.
The solitary Spanish-speaking patient who used a phone interpreter in the counseling session and
had no Spanish-speaking providers was one of the only parents to report confusion and low
satisfaction with the information provided. This study illuminates the increased patient
comprehension that can be provided by a bilingual staff and suggests that always having a
Spanish-speaking provider on staff and simply asking a patient if they would prefer that Spanishspeaking provider allows greater understanding by Spanish speaking patients.
Several of our participants reported difficulties finding additional resources in Spanish,
such as focus groups or literature on the internet. A similar need for culturally-appropriate
materials was found among New York Latinos in the cancer genetics setting by Sussner et al.
(2009), and in a group of Salt Lake area Latinos in Kinney et al. (2010). Our participants

described using Spanish language resources for providing themselves with helpful information
but also as being used as a resource for educating extended family members who do not speak
English.
Although a minority of bilingual parents preferred using Spanish in the sessions with
providers for the benefit of Spanish speaking family members also present, almost all of the
parents who spoke some English expressed a preference to speak with their providers in English.
This occurred even when the provider spoke Spanish and was attributed to ignorance of medical
terminology in Spanish or concern that Spanish language encounters with providers could
become an impediment to medical care. This indicates that although Spanish may be their first
language and the language that they are most comfortable using, for those who are bilingual,
there is a level of discomfort when using Spanish with providers.
Another barrier that has been explored is the cost of genetic testing. Cost and lack of
insurance have previously been found to be the most frequent barriers for BRCA1/2 testing in
Latinos in New York City (Kinney et al., 2010). Our study found almost no concern or even
discussion of financial costs when testing was ordered among our parents, though our cohort is
refined for those who already received testing. Five parents either did, or indicated that they
would have, paid at least $300 for the cost of testing. Only two parents claimed to have been
unable to afford any cost whatsoever.
Sharing of results
A study by Velicer et al. found that women who intended to pursue genetic testing were
twice as likely to have spoken to relatives about the testing (2001). This is consistent with our
study, where participants who already had testing were generally willing to share their test
results with providers, family, and friends, with only one parent stating they only shared the

results with their child’s other parent but no other family members. Other studies have found
Latinos to be more likely to share medical information or involve family members in the
decision-making process with a cancer diagnosis (Maly et al., 2006), and family history of
cancer risk (Corona et al., 2012).
Study Limitations
There are several limitations to our study. All parents received care at a single institution.
Parents were cared for by seven GCs and five geneticists, and differences in how each individual
provider practices may have affected the experiences of the participants. While it is a strength of
our study that we conducted interviews in both Spanish and English, the Spanish and English
interviews were conducted by separate individuals and there is potential that information is lost
in the translation of the Spanish interviews. All quotes from the Spanish language interviews
were translated back into Spanish by a native speaker to confirm the original translation was
correct, though there is debate in the literature about whether it is appropriate to analyze
interviews in two different languages in a single study. Additionally, the Spanish-language
interviews were conducted by a genetic counselor fluent in Spanish but not a native speaker,
however a native speaker was present and assisted in any linguistic difficulties. All interviews
were conducted by phone, and the lack of nonverbal cues may have influenced the interviews
and therefore our results. The timing of the interview from when the parent had received the
results varied from three months to one year and nine months. We specifically elected not to
complete an interview less than three months from receiving results to limit the immediate and
sometimes transient reactions to results. The timing likely resulted in some recall bias.
We attempted to capture a diverse sample of Latino/a parents of child with diverse types
of CES results. This diversity may have limited our ability to capture more subtle themes

experienced within parents of a certain acculturation or with specific types of results. As all of
the participants had already undergone CES, our participants are representative of only this subsample. In addition, the term Latino refers to a heterogenous group of peoples. The Latino
population in our study are those living in New York, who are primarily from the Dominican
Republic and Puerto Rico by descent. The experiences we observed may differ from experiences
of other Latinos with different ancestries and cultures.
Practice Implications
Many of the parents in our study understood CES as an investigation of many genes and
were confused or relieved when no genetic cause was discovered after testing. This finding
suggests that a more thorough explanation of the limitations and negative predictive value of
testing needs to be conveyed to patients. Several patients seemed to be unaware of the possibility
of an undetected genetic cause. Likewise, some parents misunderstood the implication of results
which were de novo and had decided to forgo having additional children due to the risk of
recurrence. Additional time is needed in sessions to convey the recurrence risk of de novo
conditions and explain why there may be no family history.
To address the anxiety of the waiting process, placing emphasis on the average
turnaround time multiple times during the consult may be helpful. In addition, psychosocial
counseling and support should be provided throughout the process, from pre-results to postresults, to alleviate and explore any concerns parents may have. Providing a visual timeline that
illustrates the process of CES that highlights the average wait time for return of results may also
be supportive in generating realistic expectations. Some parents may find it helpful to connect
with other parents who have had CES for their child. These parents may be a source of comfort

or a more accurate resource during the wait time. If possible, Latino parents should be connected
to each other, as the cultural and language aspects may provide an extra level of comfort.
The Latino parents in our study did not differentiate between CES testing and previous
genetic testing performed, suggesting that extensive information about the specific genetic tests
may not be needed. Instead, it may be helpful to focus on the differences between a positive,
negative, and VUS result, and what these results could mean for their family, their child, and
their child’s medical management. This information may be further useful as in the form of
written documentation, available to Latino parents in both Spanish and English regardless of
what language they used in the results session. To support parents who are more comfortable
speaking Spanish but lack confidence in speaking Spanish with providers, better educational
materials can be developed to help them understand medical terminology in Spanish. In addition,
acknowledging the role of faith and God in the parental experience of CES for their child may
also be conducive to the establishing a stronger bond between the provider and parent.
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Appendix I. Study Participants
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Appendix V. Quotations from Parents

Appendix VI. Interview Script
Introduction
● Tell me a little bit about why your child was referred to genetics or why you sought a
genetics evaluation.
● How and when did you first hear about exome sequencing? (Probe to find out when they
first heard about it, who told them about it, or where they heard/read about it)
● What were your first feelings or thoughts about whether this was something you wanted
to consider for your child? What did you think this could add to your child’s care? What
was your attitude towards genetic testing prior to getting the test done?
● When making the decision about whether to do the genetic testing or not, did you seek
input from other doctors or medical professionals beyond your genetics team? Apart
from medical professionals, did you ask anybody else their opinion about what you
should do? (If yes) Who was that and why did you ask them for advice? What were the
most important reasons why you decided to have the testing done?
Pre-test/Consent Visit
● After hearing about the test, what resources did you use to learn more?
● Is there information you wish you had been given or understood before your child had the
test? (If yes) What information is that? (probe about if they understood what positive,
negative, VUS, and secondary finding results meant)
● What were your hopes and expectations about the results for this test?
● What were your reservations and doubts about this test?
● Could we have done a better job discussing the testing during your visit? How so?
Language
● What language did you use to speak with the doctor about the test? With the genetic
counselor?
● Was this the language you felt most comfortable speaking in about this topic? If no, what
would you have preferred?
● Did you use a translator/interpreter? If yes, who? Was the translator/interpreter on the
phone, in person, a relative/friend at the appointment? How was this experience?
● Did you have any difficulty finding other resources in your preferred language?
Cost/Logistics
What made you decide to go to the genetics appointment? Did you think about not going
or cancelling the appointment? Why?
● Did you take a day off work to attend the appointment? Did you need childcare for your
other children to attend the appointment?
● What other arrangements, if any, did you make in order to attend the appointment?
•

● How did you travel to the appointment? How did you pay for this transportation?
● Do you remember if the entire cost of the testing was covered by your insurance or if you
had to pay any part of the cost? (If had to pay some part of cost) How much did you have
to pay?
● Did you consider the cost of testing when deciding whether or not to have it?
● Did you receive any assistance (from friends or family members) to help you to pay for
the test?
● How much would you have been able and willing to pay for the test if your insurance had
not covered it?
Understanding of results
● Who told you the results for the first time? The second time?
● How did they communicate the results for each discussion (e.g., in face-to-face meeting
with physician, by mail, by telephone)?
● What language did the provider speak to tell you about the results? Was this your
preference? Was an interpreter used? Who?
● Were you satisfied with how you learned the results? If not, how could this experience
have been better? (by phone, in person, with someone else present?)
● Did you feel the results were communicated in a way that enabled you to understand
what they meant for your child? What would you have liked to have been done
differently?
● How do you feel about the results and why? What have the positives and negatives been
about having this result?
● Are your feelings about the results what you expected they would be? If not, how are
they different from what you expected?
● Did you have any misunderstandings about the test results that you understand better
now?
● Did you look for any additional information about your child’s results online or
somewhere else? Where did you find information? Did you find that information
helpful? Not helpful?
Social Impact
● Did you share the results with your child’s other parent? What was his/her response?
Was it the same or different to your reaction? Was his/her reaction helpful or harmful? In
what way?
● Who did you share your child’s results with? Did you share your test results with any
other family members, friends, your child’s teachers?
● Did you share your test results with your child’s therapists/doctors? Which doctors?
What was their reaction?

● Have the results changed their perceptions/feelings about your child? Have the test
results changed your interactions with these people? Brought you closer? Weakened your
relationship? Caused conflict?
● Have any of your family members had genetic testing after learning about your child’s
test results? (inherited conditions only)
● Are there family members you decided not to share the results with? (If yes) Why did you
decide not to share the results with them?
Life Impact
● Have the results allowed you to join any specific support groups, research studies or meet
other individuals with the same condition? If so, what impact did that have? If not, what
prevented you from finding/joining support groups? Were you unaware that these groups
were available to you? Uninterested? Could not find a group in your preferred language?
● Did anything negative happen to you in your job, insurance, or other areas of your life
because of the results you received?
Decision Satisfaction/Regret
● Overall, how do you feel about your decision to have testing for your child?
● Currently, what do you think has been the greatest benefit from the test?
● If you were able to go back and choose the most optimal time for your child to have this
test, when would you have liked to have it done? (probe to find out if they wanted it
before a certain age or symptom onset)
● What would you have changed about this experience?
In Conclusion
● What do you think has been the most difficult part of the entire process from when you
first began thinking about having the test through getting the result?
● Is there any kind of additional information or support that would have been helpful for
you to have at any point in the process? (If yes) What kinds?
● What advice would you give other parents contemplating this test for their child?
● We are specifically trying to learn more about the experience of having this kind of
testing in Latino families. How do you think your experience may have been different
from people from other cultures or ethnicities?
● Before we end, is there anything else you would like to say about the whole exome
sequencing experience?
Introduce that we will be sending them an electronic link/ paper survey with 8 questions
$25 gift card.

